7UCE image
Entry Detail
PDB ID:
7UCE
Title:
Structure of the anti-HIV-1 neutralizing antibody BG24 Fab fragment
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-03-16
Release Date:
2022-08-17
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:BG24 Fab heavy chain
Chain IDs:B (auth: H)
Chain Length:234
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:BG24 Fab light chain
Chain IDs:A (auth: L)
Chain Length:205
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
A naturally arising broad and potent CD4-binding site antibody with low somatic mutation.
Sci Adv 8 eabp8155 eabp8155 (2022)
PMID: 35960796 DOI: 10.1126/sciadv.abp8155

Abstact

The induction of broadly neutralizing antibodies (bNAbs) is a potential strategy for a vaccine against HIV-1. However, most bNAbs exhibit features such as unusually high somatic hypermutation, including insertions and deletions, which make their induction challenging. VRC01-class bNAbs not only exhibit extraordinary breadth and potency but also rank among the most highly somatically mutated bNAbs. Here, we describe a VRC01-class antibody isolated from a viremic controller, BG24, that is much less mutated than most relatives of its class while achieving comparable breadth and potency. A 3.8-Å x-ray crystal structure of a BG24-BG505 Env trimer complex revealed conserved contacts at the gp120 interface characteristic of the VRC01-class Abs, despite lacking common CDR3 sequence motifs. The existence of moderately mutated CD4-binding site (CD4bs) bNAbs such as BG24 provides a simpler blueprint for CD4bs antibody induction by a vaccine, raising the prospect that such an induction might be feasible with a germline-targeting approach.

Legend

Protein

Chemical

Disease

Primary Citation of related structures